selected publications

• article

  • An Algae-Made RBD from SARS-CoV-2 Is Immunogenic in Mice.  Pharmaceuticals.  15:-. 2022-01-01
  • Carrot cells expressing the VP1 and VP2 poliovirus proteins effectively elicited mucosal immunity.  Plant Cell, Tissue and Organ Culture.  148:545-556. 2022-01-01
  • Production and Purification of LTB-RBD: A Potential Antigen for Mucosal Vaccine Development against SARS-CoV-2.  Vaccines.  10:-. 2022-01-01
  • Production and characterization of chimeric SARS-CoV-2 antigens based on the capsid protein of cowpea chlorotic mottle virus.  International Journal of Biological Macromolecules.  213:1007-1017. 2022-01-01
  • Serum zinc levels are associated with obesity and low-density lipoprotein cholesterol in Mexican adults.  Journal of Trace Elements in Medicine and Biology.  73:-. 2022-01-01
  • Expression of immunogenic poliovirus Sabin type 1 VP proteins in transgenic tobacco.  Journal of Biotechnology.  322:10-20. 2020-01-01
  • Inducible expression of antigens in plants: a study focused on peptides related to multiple sclerosis immunotherapy.  Journal of Biotechnology.  318:51-56. 2020-01-01
  • Using carrot cells as biofactories and oral delivery vehicles of LTB-Syn: A low-cost vaccine candidate against synucleinopathies.  Journal of Biotechnology.  309:75-80. 2020-01-01
  • Arsenic removal using Chlamydomonas reinhardtii modified with the gene acr3 and enhancement of its performance by decreasing phosphate in the growing media.  International Journal of Phytoremediation.  21:617-623. 2019-01-01
  • Design of a multiepitopic Zaire ebolavirus protein and its expression in plant cells.  Journal of Biotechnology.  295:41-48. 2019-01-01
  • Genetically-engineered plants yield an orally immunogenic PirA-like toxin from Vibrio parahaemolyticus.  International Journal of Biological Macromolecules.  137:126-131. 2019-01-01
  • Assessment of Carrot Callus as Biofactories of an Atherosclerosis Oral Vaccine Prototype.  Molecular Biotechnology.  59:482-489. 2017-01-01
  • Expression of an immunogenic LTB-based chimeric protein targeting Zaire ebolavirus epitopes from GP1 in plant cells.  Plant Cell Reports.  36:355-365. 2017-01-01
  • LTB-Syn: a recombinant immunogen for the development of plant-made vaccines against synucleinopathies.  Planta.  245:1231-1239. 2017-01-01
  • Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells.  Planta.  243:675-685. 2016-01-01
  • A Plant-Derived Multi-HIV Antigen Induces Broad Immune Responses in Orally Immunized Mice.  Molecular Biotechnology.  57:662-674. 2015-01-01
  • Chloroplast expression of an HIV envelop-derived multiepitope protein: Towards a multivalent plant-based vaccine.  Plant Cell, Tissue and Organ Culture.  116:111-123. 2014-01-01
  • Expression of an HBcAg-based antigen carrying angiotensin II in Chlamydomonas reinhardtii as a candidate hypertension vaccine.  Plant Cell, Tissue and Organ Culture.  116:133-139. 2014-01-01
  • Immunogenic properties of a lettuce-derived C4(V3)6 multiepitopic HIV protein.  Planta.  238:785-792. 2013-01-01
  • Production of an antigenic C4(V3)6 multiepitopic HIV protein in bacterial and plant systems.  Plant Cell, Tissue and Organ Culture.  113:73-79. 2013-01-01
  • A chloroplast-derived C4V3 polypeptide from the human immunodeficiency virus (HIV) is orally immunogenic in mice.  Plant Molecular Biology.  78:337-349. 2012-01-01
  • Immunogenicity of nuclear-encoded LTB:ST fusion protein from Escherichia coli expressed in tobacco plants.  Plant Cell Reports.  30:1145-1152. 2011-01-01

• chapter

  • Plant-based vaccines against neglected tropical diseases.  Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View. 141-160. 2014-01-01
  • Plant-based vaccines against the human immunodeficiency virus.  Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View. 161-173. 2014-01-01
  • Plant-based vaccines as a global vaccination approach: Current perspectives.  Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View. 265-280. 2014-01-01
  • Principles of plant-based vaccines.  Genetically Engineered Plants as a Source of Vaccines Against Wide Spread Diseases: An Integrated View. 1-14. 2014-01-01
• Nanoclays: Promising Materials for Vaccinology.  Vaccines. -. 2022-01-01
• An overview of tolerogenic immunotherapies based on plant-made antigens.  Expert Opinion on Biological Therapy. 587-599. 2019-01-01
• Progress and future opportunities in the development of vaccines against atherosclerosis.  Expert Review of Vaccines. 337-350. 2017-01-01
• An overview of bioinformatics tools for epitope prediction: Implications on vaccine development.  Journal of Biomedical Informatics. 405-414. 2015-01-01
• The potential of plants for the production and delivery of human papillomavirus vaccines.  Expert Review of Vaccines. 1031-1041. 2015-01-01
• Plant-based vaccines for Alzheimer's disease: An overview.  Expert Review of Vaccines. 429-441. 2014-01-01
• Engineering production of antihypertensive peptides in plants.  Plant Cell, Tissue and Organ Culture. 159-169. 2013-01-01
• Current status and perspectives of plant-based candidate vaccines against the human immunodeficiency virus (HIV).  Plant Cell Reports. 495-511. 2012-01-01
• Developing plant-based vaccines against neglected tropical diseases: Where are we?.  Vaccine. 40-48. 2012-01-01